Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for macrophagic myofasciitis has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for macrophagic myofasciitis.
5 publications have been identified in PubMed for macrophagic myofasciitis. Research spans Review / Meta-Analysis (50%), Diagnostic / Biomarker (25%), and Basic Science / Preclinical (25%).
Doyon-Plourde P (2026). [PMID: 42091164](https://pubmed.ncbi.nlm.nih.gov/42091164/). *BMJ*. [Review / Meta-Analysis]
Chang JR (2025). [PMID: 39994837](https://pubmed.ncbi.nlm.nih.gov/39994837/). *J Cutan Pathol*. [Diagnostic / Biomarker]
Shiro R (2025). [PMID: 41048017](https://pubmed.ncbi.nlm.nih.gov/41048017/). *Cancer science*. [Review / Meta-Analysis]
Masson JD (2024). [PMID: 39058143](https://pubmed.ncbi.nlm.nih.gov/39058143/). *Toxics*. [Basic Science / Preclinical]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 12:50 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center